<VariationArchive RecordType="classified" VariationID="988997" VariationName="NM_020919.4(ALS2):c.326del (p.Asn109fs)" VariationType="Deletion" Accession="VCV000988997" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-05-16" MostRecentSubmission="2021-05-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="976926" VariationID="988997">
      <GeneList>
        <Gene Symbol="ALS2" FullName="alsin Rho guanine nucleotide exchange factor ALS2" GeneID="57679" HGNC_ID="HGNC:443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201700267" stop="201780933" display_start="201700267" display_stop="201780933" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202564985" stop="202645894" display_start="202564985" display_stop="202645894" Strand="-" />
          </Location>
          <OMIM>606352</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020919.4(ALS2):c.326del (p.Asn109fs)</Name>
      <CanonicalSPDI>NC_000002.12:201761667:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201761668" stop="201761668" display_start="201761668" display_stop="201761668" variantLength="1" positionVCF="201761667" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202626391" stop="202626391" display_start="202626391" display_stop="202626391" variantLength="1" positionVCF="202626390" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>N109fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_654" sequenceAccession="LRG_654">
            <Expression>LRG_654:g.24505del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_654t1" sequenceAccession="LRG_654t1">
            <Expression>LRG_654t1:c.326del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_654p1" sequenceAccession="LRG_654p1" change="p.Asn109fs">
            <Expression>LRG_654p1:p.Asn109fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.202626392del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.202626392del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.201761669del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.201761669del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008775.1" sequenceAccession="NG_008775" sequenceVersion="1" change="g.24505del">
            <Expression>NG_008775.1:g.24505del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135745.2" sequenceAccession="NM_001135745" sequenceVersion="2" change="c.326del">
            <Expression>NM_001135745.2:c.326del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001129217.1" sequenceAccession="NP_001129217" sequenceVersion="1" change="p.Asn109fs">
            <Expression>NP_001129217.1:p.Asn109fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020919.4" sequenceAccession="NM_020919" sequenceVersion="4" change="c.326del" MANESelect="true">
            <Expression>NM_020919.4:c.326del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065970.2" sequenceAccession="NP_065970" sequenceVersion="2" change="p.Asn109fs">
            <Expression>NP_065970.2:p.Asn109fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2106089798" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020919.4(ALS2):c.326del (p.Asn109fs) AND Infantile-onset ascending hereditary spastic paralysis" Accession="RCV001391369" Version="1">
        <ClassifiedConditionList TraitSetID="1214">
          <ClassifiedCondition DB="MedGen" ID="C2931441">Infantile-onset ascending hereditary spastic paralysis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-16" MostRecentSubmission="2021-05-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1214" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4157" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Autosomal Recessive Juvenile Amyotrophic Lateral Sclerosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paralysis, infantile onset ascending</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Infantile-onset ascending hereditary spastic paralysis</ElementValue>
                <XRef ID="Infantile-onset+ascending+hereditary+spastic+paralysis/3819" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011797" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IAHSP</ElementValue>
                <XRef Type="MIM" ID="607225" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ALS2-related disorder involves retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprises a clinical continuum of the following three phenotypes: Infantile ascending hereditary spastic paraplegia (IAHSP), characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome caused by progressive cranial nerve involvement. Juvenile primary lateral sclerosis (JPLS), characterized by upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. Juvenile amyotrophic lateral sclerosis (JALS or ALS2), characterized by onset between ages three and 20 years. All affected individuals show a spastic pseudobulbar syndrome (spasticity of speech and swallowing) together with spastic paraplegia. Some individuals are bedridden by age 12 to 50 years.</Attribute>
                <XRef ID="NBK1243" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000249543" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514976" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528540" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4914" />
                <XRef ID="4914" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301421</ID>
                <ID Source="BookShelf">NBK1243</ID>
              </Citation>
              <XRef ID="293168" DB="Orphanet" />
              <XRef ID="C2931441" DB="MedGen" />
              <XRef ID="MONDO:0011797" DB="MONDO" />
              <XRef Type="MIM" ID="607225" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2865887" SubmissionDate="2020-11-14" DateLastUpdated="2021-05-16" DateCreated="2021-05-16">
        <ClinVarSubmissionID localKey="NM_020919.4:c.326del|OMIM:607225" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001451105" DateUpdated="2021-05-16" DateCreated="2021-05-16" Type="SCV" Version="1" SubmitterName="Paris Brain Institute, Inserm - ICM" OrgID="507826" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020919.4:c.326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607225" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8526155</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2865887" TraitType="Disease" MappingType="XRef" MappingValue="607225" MappingRef="OMIM">
        <MedGen CUI="C2931441" Name="Infantile-onset ascending hereditary spastic paralysis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

